Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision v3.4.2 was added to the history; the prior funding notice and v3.4.1 entry were removed.
    Difference
    0.8%
    Check dated 2026-02-11T02:33:31.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice regarding government funding delays and updated the revision from v3.4.0 to v3.4.1.
    Difference
    0.8%
    Check dated 2026-02-03T23:44:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option, color-coded highlights for additions (green) and deletions (red) in the study history, and a revision note showing v3.4.0 replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-27T20:55:01.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study data or page content, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T15:34:50.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The record now shows Active, not recruiting and an updated title reflecting Relapse/Refractory AML. It also adds new sections including IPDSharing, Contacts/Locations, Study Design, Conditions, Study Description, Oversight, Sponsor/Collaborators, and Recruitment Status.
    Difference
    2%
    Check dated 2026-01-06T03:21:04.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Added a new revision entry (Revision: v3.3.3) to the study's Record History. Removed the HHS Vulnerability Disclosure item and Revision: v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-22T23:56:21.000Z thumbnail image

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.